2014至2022年日本转运至重症医疗中心的院外心脏骤停患者结局的时间趋势:全国性回顾性观察研究
该研究基于日本急性医学会院外心脏骤停(JAAM-OHCA)登记,纳入2014年6月1日至2022年12月31日转运至重症医疗中心(CCMCs)的61,725例成人非创伤性院外心脏骤停患者,按2014-2016、2017-2019、2020-2022三个日历时段比较结局。神经功能良好结局比例从3.6%降至3.3%再降至2.5%;以2014-2016为参照,2017-2019的调整比值比(aOR)为1.01(95%CI 0.89-1.15),2020-2022为0.83(95%CI 0.72-0.94)。30天生存率同期从6.9%降至6.8%再降至5.4%。但在体外心肺复苏(ECPR)候选者中,2020-2022较2014-2016神经功能结局改善,aOR为1.43(95%CI 1.06-1.93)。作者认为,及时且有针对性的复苏后干预可能改善特定人群的结局。
要点
- 2020-2022时段转运至CCMCs的OHCA患者神经功能良好结局aOR为0.83(95%CI 0.72-0.94),低于2014-2016时段。
- 神经功能良好结局比例从2014-2016的3.6%降至2017-2019的3.3%,再降至2020-2022的2.5%。
- 30天生存率从2014-2016的6.9%降至2017-2019的6.8%,再降至2020-2022的5.4%。
- 在ECPR候选者中,2020-2022较2014-2016神经功能良好结局改善,aOR为1.43(95%CI 1.06-1.93)。
- 作者认为,及时且有针对性的复苏后干预可能改善特定人群的结局。
适用人群与场景
- 成人(≥18岁)非创伤性院外心脏骤停患者,转运至日本重症医疗中心(CCMCs),且具备Utstein风格院前数据。
研究设计与关键结果
- 研究类型为回顾性队列研究,基于日本全国多中心JAAM-OHCA登记,纳入2014年6月1日至2022年12月31日转运至CCMCs的61,725例成人非创伤性OHCA患者。
- 神经功能良好结局比例:2014-2016为3.6%,2017-2019为3.3%,2020-2022为2.5%。
- 以2014-2016为参照,神经功能良好结局的aOR:2017-2019为1.01(95%CI 0.89-1.15),2020-2022为0.83(95%CI 0.72-0.94)。
- 30天生存率:2014-2016为6.9%,2017-2019为6.8%,2020-2022为5.4%。
- 在多数预设亚组中观察到相似趋势。
- 在ECPR候选者中,2020-2022较2014-2016神经功能良好结局改善,aOR为1.43(95%CI 1.06-1.93)。
证据类型、等级与局限
- 证据类型:回顾性队列研究(全国性多中心登记)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,及时且有针对性的复苏后干预可能改善特定人群的结局。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: To evaluate temporal trends in clinical outcomes among nontraumatic out-of-hospital cardiac arrest (OHCA) patients transported to critical care medical centers (CCMCs) in Japan.
DESIGN: Retrospective cohort study.
SETTING: Nationwide multicenter registry involving CCMCs in Japan, which are government-designated advanced emergency care institutions specializing in intensive resuscitation and post-cardiac arrest management. Data were obtained from the Japanese Association for Acute Medicine OHCA (JAAM-OHCA) registry from June 1, 2014, to December 31, 2022.
PATIENTS: Adult patients (≥ 18 yr old) with nontraumatic OHCA who were transported to CCMCs and had Utstein-style prehospital data available. Patients were categorized into three calendar periods (2014-2016, 2017-2019, and 2020-2022) for temporal comparison.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Among 61,725 eligible patients, the proportion with favorable neurologic outcomes decreased from 3.6% (2014-2016) to 3.3% (2017-2019) and further to 2.5% (2020-2022). Using multivariable logistic regression, the adjusted odds ratios (aORs) for favorable neurologic outcome were 1.01 (95% CI, 0.89-1.15) in 2017-2019 and 0.83 (95% CI, 0.72-0.94) in 2020-2022, compared with 2014-2016. Similarly, 30-day survival declined during the same period, from 6.9% to 6.8% and 5.4%. In most predefined subgroups, similar trends were observed. In contrast, neurologic outcomes improved among candidates for extracorporeal cardiopulmonary resuscitation (ECPR), with an aOR of 1.43 (95% CI, 1.06-1.93) in 2020-2022 compared with 2014-2016.
CONCLUSIONS: Outcomes among OHCA patients transported to CCMCs remained stable until 2019 but declined during the COVID-19 pandemic period. However, improved outcomes among patients eligible for ECPR suggest that timely and targeted post-arrest interventions may improve outcomes in selected populations.
参考来源
- Shiozumi T, Matsuyama T, Imamura T, et al. Temporal Trends in Outcomes After Out-of-Hospital Cardiac Arrest Transported to Critical Care Medical Centers in Japan, 2014-2022: A Nationwide Retrospective Observational Study. Crit Care Med. 2026. PMID: 41848362. doi:10.1097/CCM.0000000000007104
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。